Literature DB >> 916094

Topical instillation of doxorubicin hydrochloride in the treatment of recurring superficial transitional cell carcinoma of the bladder.

M D Banks, J E Pontes, R M Izbicki, J M Pierce.   

Abstract

Thirteen patients with recurring stage A transitional cell carcinoma of the bladder were treated with monthly bladder instillations of doxorubicin hydrochloride. Follow-up at 3-month intervals has shown excellent control of tumor recurrence with complete remissions for up to 21 months in 2 patients. The median for remission in 8 of 13 patients has been 10 months. Two patients with bladder papillomatosis were treated successfully by the same method.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 916094     DOI: 10.1016/s0022-5347(17)58182-3

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  12 in total

1.  Verapamil enhanced in vitro chemosensitivity of a murine bladder carcinoma, FCB.

Authors:  R J Ballou; W G Simpson; J I Harty; M T Tseng
Journal:  Urol Res       Date:  1986

2.  Approaches to the treatment of bladder cancer at Stanford.

Authors:  F M Torti
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

Review 3.  Intravesical chemotherapy in the United States. An overview.

Authors:  J T Spaulding
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

4.  Plasma pharmacokinetics of adriamycin after intrapleural administration.

Authors:  S Eksborg; A Lindfors; B J Cedermark
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

5.  Early adjuvant adriamycin in superficial bladder carcinoma.

Authors:  C C Schulman; L J Denis; W Oosterlinck; W De Sy; M Chantrie; C Bouffioux; P J Van Cangh; P Van Erps
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

6.  Effects of intravesical instillation of antitumor drugs on the induction of preneoplastic bladder lesions in rats.

Authors:  M Ohtani; S Fukushima; N Ito; K Koiso; T Niijima
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

7.  Cooperative studies of chemoprophylaxis after transurethral resection of bladder tumors.

Authors:  M Pavone-Macaluso; M Tripi; G B Ingargiola
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

8.  Prophylactic use of topical adriamycin after transurethral resection of transitional cell bladder tumours.

Authors:  J Flamm; F Grof
Journal:  Int Urol Nephrol       Date:  1985       Impact factor: 2.370

9.  Bladder instillation of adriamycin in the treatment of bladder cancer.

Authors:  C H Huang; C P Chiang
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

10.  Intravesical therapy with adriamycin and 4-epirubicin for superficial bladder cancer: the experience of the EORTC GU Group.

Authors:  A P van der Meijden; K H Kurth; W Oosterlinck; F M Debruyne
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.